Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

SHE:301089 Revenue

Tuoxin Pharmaceutical Group had revenue of 111.48M CNY in the quarter ending September 30, 2026, with 24.35% growth. This brings the company's total for the last twelve months to 429.58M, up 16.89% year-over-year. In the year 2025, Tuoxin Pharmaceutical Group had annual revenue of 378.34M, down -10.28%. That makes Tuoxin Pharmaceutical Group the 26,067th largest company in the world by revenue and 4,588th in China.

• Revenue (ttm): 429.58M
• Revenue Growth: +16.89%
• P/S Ratio: 6.19
• Revenue / Employee: 278.40K
• Employees: 1,543
• Market Cap: 2.60B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 288.51M 76.3%
• Overseas 89.84M 23.7%

Fiscal year ended Dec 31, 2025 See the full SHE:301089 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	378.34M	-43.35M	-10.28%
Dec 31, 2024	421.69M	-413.82M	-49.53%
Dec 31, 2023	835.51M	50.79M	6.47%
Jan 1, 2023	784.72M	282.24M	56.17%
Jan 1, 2022	502.48M	-25.46M	-4.82%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error